Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Sheng Guo

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Theranostics|June 7, 2021
Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulationLingjuan Chen, Hongqi Chen, Junjie Ye, et al.
Cancer Research|November 4, 2005
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2Z Sheng Guo, Arpana Naik, Mark E O'Malley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonistsPetar J Popovic, Richard DeMarco, Michael T Lotze, et al.
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.
Cancer Research|January 21, 2006
De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor modelZ Sheng Guo, Julie A Hong, Kari R Irvine, et al.
Cancer Research|February 9, 2012
Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancerLiza B John, Linda J Howland, Jacqueline K Flynn, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Theranostics|June 7, 2021
Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulationLingjuan Chen, Hongqi Chen, Junjie Ye, et al.
Cancer Research|November 4, 2005
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2Z Sheng Guo, Arpana Naik, Mark E O'Malley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonistsPetar J Popovic, Richard DeMarco, Michael T Lotze, et al.
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.
Cancer Research|January 21, 2006
De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor modelZ Sheng Guo, Julie A Hong, Kari R Irvine, et al.
Cancer Research|February 9, 2012
Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancerLiza B John, Linda J Howland, Jacqueline K Flynn, et al.
Pageof 3